Hims & Hers looks undervalued with 88% YoY growth, ZAVA scaling, and solid support near $41, despite risks and high short interest. Learn why HIMS stock is a buy.
Hims & Hers Health: Still Undervalued (NYSE:HIMS)
Seeking Alpha Stock08/31
127
Seeking Alpha Stock08/31
Reuters US Business
Reuters US Economy
The Motley Fool
New York PostLooks like you've reached the bottom